Company Overview and News

 
Publication of Offering Circular

2017-05-26 londonstockexchange
The following Offering Circular has been approved by the UK Listing Authority and is available for viewing:

 
Termination of Tender Offers

2017-03-31 londonstockexchange
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

 
Result of Tender Offer

2017-03-28 londonstockexchange
Anglo American Capital plc announces final results and pricing of Tender Offers for certain of its Notes

 
Indicative Results of Tender Offers

2017-03-28 londonstockexchange
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

 
Anglo American announces Tender Offers

2017-03-20 londonstockexchange
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

 
Anglo American launches Cash Tender Offers

2017-03-20 londonstockexchange
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

 
Invitation to non-US and US bond holders

2017-03-20 londonstockexchange
NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT

 
Publication of Offering Circular

2017-03-15 londonstockexchange
The following Offering Circular has been approved by the UK Listing Authority and is available for viewing:

 
How Bond Buybacks Add Value

2016-07-18 marketrealist
Companies typically establish a tender offer price that is a premium to a bond’s current price in order to entice investors to sell. As of June 30, 2016, 11 fallen angel companies had issued tender offers YTD (year-to-date), boosting their bonds’ prices by 5% on average between the day prior to and the day after the tender offer. Mainly, from basic industry and energy sector issuers, five of the 11 firms were fallen angel entrants in 2016: Ensco, Encana, Noble Holdings, Anglo American Capital, and Southwestern Energy Company.

 
Fallen Angels Boosted By Bond Buyback Premiums

2016-07-12 seekingalpha
Fallen angel bonds, high yield bonds originally issued with investment grade credit ratings, are generally known for offering potential value. A big source of this value has been the tendency of fallen angels to be oversold, to below what may be considered fair value, leading up to their downgrade to high yield.

 
Annual Report to shareholders

2016-03-29 asx.com.au

 
Anglo American Capital plc announces Final Results of Tender Offers for certain of its Securities

2016-03-17 prnewswire
NEW YORK, March 17, 2016 /PRNewswire/ -- Anglo American Capital plc (the "Company") invited holders of such of its outstanding securities as are listed below (together, the "Securities") to tender some or all of their Securities to the Company for purchase by the Company for cash (the "Tender Offers"), for an aggregate consideration of up to U.S.$300,000,000, upon the terms and subject to the conditions set out in the tender offer memorandum dated February 18, 2016 (the "Tender Offer Memorandum") prepared by the Company.

 
Final Results of Tender Offer for Securities

2016-03-17 londonstockexchange
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL (SEE "DISTRIBUTION RESTRICTIONS" BELOW)

 
Invitation to US bond holders to tender for cash

2016-02-18 londonstockexchange
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL (SEE "OFFER AND DISTRIBUTION RESTRICTIONS" BELOW)

 
Invitation to Note holders to tender for cash

2016-02-18 londonstockexchange
NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT (SEE "OFFER AND DISTRIBUTION RESTRICTIONS" BELOW)

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

19h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...